3,4-dihydroxyphenylacetic acid and reboxetine

3,4-dihydroxyphenylacetic acid has been researched along with reboxetine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connor, TJ; Harkin, A; Kelliher, P; Kelly, JP; Leonard, BE1
Björkholm, C; Jardemark, K; Malmerfelt, A; Marcus, MM; Nyberg, S; Schilström, B; Svensson, TH1
Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM1
Aonurm-Helm, A; Kaenmaki, M; Mannisto, PT; Tammimaki, A1

Other Studies

4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and reboxetine

ArticleYear
Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
    European journal of pharmacology, 1999, Aug-27, Volume: 379, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Brain Chemistry; Corticosterone; Defecation; Dopamine; Dose-Response Relationship, Drug; Immobilization; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin; Stress, Physiological; Swimming

1999
Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Dibenzothiazepines; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Membrane Potentials; Morpholines; N-Methylaspartate; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Pyramidal Cells; Quetiapine Fumarate; Raclopride; Rats; Reboxetine

2013
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
    Psychoneuroendocrinology, 2013, Volume: 38, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology

2013
Elimination of extracellular dopamine in the medial prefrontal cortex of conscious mice analysed using selective enzyme and uptake inhibitors.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016, Volume: 67, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dopamine; Female; Homovanillic Acid; Male; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase Inhibitors; Morpholines; Nitrophenols; Pargyline; Prefrontal Cortex; Reboxetine; Synaptosomes; Tolcapone

2016